DSD-C118
Congenital adrenal hyperplasia · 46,XX · DSD-C118
Classic salt-wasting 21-hydroxylase deficiency (congenital adrenal hyperplasia), CYP21A2 R356W homozygous mutation, 46,XX female pseudohermaphroditism (fetal androgen excess causing virilized external genitalia).
Images · 2
Case fields and evidence
- Category
-
Congenital adrenal hyperplasia
- Age
-
16 days (initial visit) to 4 months (vaginal bleeding)
- Sex
-
46,XX, identified at birth due to ambiguous genitalia, reared as female
- Karyotype
-
46,XX
- Genetics
-
CYP21A2
- Phenotypes
-
Gynecomastia (HP:0000771)
- Diagnosis
-
Classic salt-wasting 21-hydroxylase deficiency (congenital adrenal hyperplasia), CYP21A2 R356W homozygous mutation, 46,XX female pseudohermaphroditism (fetal androgen excess causing virilized external genitalia).
- Follow-up
-
Three months postoperatively metabolic control good (FSH 2.8, LH<0.07, E2<11.8, T<10); uterus still infantile (31x7x8 mm); no recurrent vaginal bleeding within 8 months.
- General phenotype
-
At 16 days: good general condition; at 4 months: no breast development or pubic hair, large mass palpable in right hemiabdomen (extending from upper abdomen to inguinal region).
- Imaging
-
Ultrasound (at diagnosis): infantile uterus and ovaries, adrenal hypertrophy; at 4 months: uterus 30x12x11 mm (no body-cervix distinction), endometrial thickness 1.5 mm, left ovary 26x10x11 mm with multiple follicles (max 5 mm), right ovary 90x80x60 mm giant uniloculated cyst with thin ovarian parenchyma.
- Laboratory findings
-
Na+: 126 mEq/L (ref 132-147; timing at diagnosis); K+: 6.87 mEq/L (ref 3.6-6.1; timing at diagnosis); Renin: 132 pg/mL (ref 5.3-99; timing at diagnosis); ACTH: 207 pg/mL (ref 0-46; timing at diagnosis); Cortisol: 7.8 ug/dL (ref 9.1-21; timing at diagnosis); 17-OHP: 21 ng/mL (ref 0.53-1.86; timing at diagnosis); Androstenedione: 5.1 ng/mL (ref 0.18-0.80; timing at diagnosis); Testosterone: 1188 ng/dL (ref 0-40; timing at diagnosis); DHEAS: >1500 ug/dL (ref 1-45; timing at diagnosis); FSH (4mo): 4.8 mIU/mL (ref 1.1-2.4; timing 4 months); LH (4mo): 2.7 mIU/mL (ref 0-1.3; timing 4 months); Estradiol (4mo): 55.3 pg/mL (ref 0-15; timing 4 months); Karyotype: 46,XX (timing at diagnosis); CYP21A2: R356W homozygous mutation (ref classic salt-wasting; timing at diagnosis)
- Management
-
Hydrocortisone + fludrocortisone replacement started at diagnosis; at 4 months right ovarian cystectomy + left small cyst aspiration; postoperative continued replacement to maintain metabolic control.
- Pathology
-
Cyst resection histology: follicular cysts; left small cyst also follicular cyst.
- Evidence level
-
See source
- Clinical history
-
See source
- Perinatal history
-
See source
- Family history
-
See source
- Growth and development
-
See source
- External genital examination
-
See source
- Limitations
-
See source
Cite this resource
DSD Research Library | Congenital adrenal hyperplasia · 46,XX · DSD-C118 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-C118?version=v1.4.0